- $19.64m
- $16.56m
- $14.24m
- 63
- 47
- 54
- 54
2019 December 31st | 2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 10.3 | 8.56 | 10.2 | 9.97 | 14.2 |
Cost of Revenue | |||||
Gross Profit | 6.08 | 4.91 | 5.63 | 4.73 | 8.4 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 13.5 | 12.8 | 13 | 14.3 | 15.8 |
Operating Profit | -3.15 | -4.28 | -2.77 | -4.33 | -1.59 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -3.4 | -4.53 | -2.78 | -4.28 | -1.57 |
Provision for Income Taxes | |||||
Net Income After Taxes | -3.18 | -4.53 | -2.78 | -4.28 | -1.57 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -3.42 | -4.77 | -4.11 | -7.38 | -1.57 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -3.42 | -4.77 | -4.11 | -7.38 | -1.57 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.453 | -0.525 | -0.35 | -0.442 | -0.152 |